Cancer antigen 125 (CA125) is considered the most useful diagnostic serum biomarker for ovarian cancer and is often used in combination with transvaginal ultrasound (TVUS) as a screening tool for detecting the disease. This evidence concerns the gene MUC16 and ovarian cancer.